《中国糖尿病杂志》官方网站

20

您的位置:首页 > 中国糖尿病杂志 > 2015年 > 11期

非增殖期糖尿病视网膜病变患者血清microRNA表达谱的分析

来自:中国糖尿病杂志  编辑:吴心池 王尧 唐伟等|点击数:|2016-02-28

      【摘要】 目的 分析非增殖期糖尿病视网膜病变(NPDR)患者血清microRNA(miRNA)表达谱的特征。 方法   选取T2DM患者60例,根据荧光素眼底血管造影结果分为糖尿病无视网膜病变(NDR)组和非增殖期糖尿病视网膜病变(NPDR)组,各30例。采用miRNA微流体芯片技术检测并筛选出两组血清中差异表达的miRNAs,RT-qPCR对部分差异表达基因进行验证。 结果   芯片检测发现,与NDR组比较,NPDR组4个血清miRNAs表达上调,5个血清miRNAs表达下调(P<0.05)。RT-qPCR验证,4个上调的miRNAs,其中,miR-19a、miR-29c、miR-4659b的差异表达有统计学意义(Z=-4.184、-4.450、-2.794,P<0.05),且受试者工作特征(ROC)曲线下面积(AUC)分别为0.814、0.834、0.710。 结论    NPDR患者血清miRNA表达谱中有9个miRNAs差异表达明显,其中,表达上调的miR-19a、miR-29c、miR-4659b可作为潜在的NPDR候选生物标志物。
      【关键词】 糖尿病视网膜病变;非增殖期;血清;微小RNA

      【Abstract】  Objective   To explore the characteristics of serum microRNA (miRNA) expression profiles in patients with non-proliferative diabetic retinopathy (NPDR). Methods    A total of 60 patients with type 2 diabetes (T2DM )were selected and divided into two groups according to their fundus fluorescein angiography results:T2DM without diabetic retinopathy(NDR group,n=30) and T2DM withnon-proliferative diabetic retinopathy (NPDR group,n=30).MiRNA with different expression in serum
of the two groups were screened and selected by miRNA microarray,in which some were validated by real-time quantitative PCR(RT-qPCR). Results   There were 4 serum miRNAs with their expression levels up-regulated and 5 serum miRNAs down-regulated in NPDR group as compared with those in NDR group shown by miRNA microarray analysis(P<0.05).RT-qPCR validation showed that among 4 up-regulated miRNAs,the difference of miR-19a,miR-29c and miR-4659b expression levels were statistically significant between two groups (Z=-4.184,-4.450,-2.794,P<0.05),and their AUC of ROC were 0.814, 0.834 and 0.710 respectively. Conclusion    There are 9 serum miRNAs with their expression levels significantly different between two groups.MiR-19a,miR-29c and miR-4659b with up-regulated expression levels may potentially serve as candidate biomarkers of NPDR.
      【Key words】 Diabetic retinopathy(DR);Non-proliferative(NPDR);Serum;microRNA(miRNA)

 

上一篇:血管内皮细胞生长因子抑制剂在新生血管性青光眼治疗中的作用 下一篇:2型糖尿病患者血糖波动与糖尿病慢性肾脏疾病及血小板源性生长因子-BB关系的研究

相关阅读

    暂时没有相关文章